care planning in pharmacy
TRANSCRIPT
Continuing Professional Pharmacy Development Program
Care Planning in Pharmacy
Nadir Kheir1, PhD, B.Pharm
Ahmed Awaisu1, Ph.D, B.Pharm
Talal Naser2, PharmD, B.Pharm
1College of Pharmacy, Qatar University, Doha, Qatar 2Hamad General Hospital, HMC, Doha, Qatar
Learning Objectives
By the end of this workshop, you will able to:
1. Discuss the context, the similarities, and the differences
between the SOAP notes and the Care Plan
2. Define the parts of a SOAP note and a Care Plan
3. Explain the aim of the care plan developed in the process
of “Pharmaceutical Care”
4. List and explain all the activities necessary to develop a
care plan and the responsibilities associated with these
activities
5. Describe the processes to be adopted in order to develop
desired goals of therapy
PCPPD-7-Care Plan-2013-NK-AA-TN
Overall Objective
• To provide the participants with the knowledge and
skills necessary to develop patient-centered and
clinically sound care plans for use in the hospital or
community pharmacy setting
PCPPD-7-Care Plan-2013-NK-AA-TN
The “What” of Care Planning? Defining Care Planning
Ahmed Awaisu, PhD
PCPPD-7-Care Plan-2013-NK-AA-TN
Defining Care Planning
• Care planning involves systematically assessing a
patient's health problems and needs, setting objectives,
performing interventions, and evaluating results
• Prioritize – Not all patients require a written PPCP
• Assess your own patients and identify specific areas on
which to focus
• Patients with specific diseases (asthma, HTN, DM,
dyslipidemia)
PCPPD-7-Care Plan-2013-NK-AA-TN
NAPRA. Developing a Pharmaceutical Care Plan. 2007.
Defining Care Planning…
Step 1. Gathering
Information
Step 2. Identifying Problems
Step 3. Assessing Problems
Step 4. Developing
the Plan
Step 5. Evaluating
Achievement of Outcomes
PCPPD-7-Care Plan-2013-NK-AA-TN
NAPRA. Developing a Pharmaceutical Care Plan. 2007.
• The development of a PPCP can be summarized as a five
step process involving the SOAP format
Defining Care Planning…
PCPPD-7-Care Plan-2013-NK-AA-TN
Defining Care Planning…
PCPPD-7-Care Plan-2013-NK-AA-TN
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: The clinician’s guide. 2nd Edition.
New York: McGraw Hill; 2004.
The “Why” of Care Planning? Reasons for Documentation
PCPPD-7-Care Plan-2013-NK-AA-TN
Reasons for Documenting Care
• A systematic way of practice
• Provides permanent record of patient encounter
• Efficient communication with others
• Provides evidence of pharmacist’s actions
• Serves as legal record of care provided
• Help back-up for billing
• Format: PWDT, MDTM,FARM,SOAP etc.
PCPPD-7-Care Plan-2013-
NK-AA-TN
The “Structure” of a Care Plan? History of Documenting a Pharmaceutical
Care Plan
PCPPD-7-Care Plan-2013-NK-AA-TN
Documenting a Care Plan
SOAP Note
Subjective Objective Assessment Plan
FARM Note
Finding Assessment Recommend Monitoring
DAP Note
Data Assessment Plan
DRP Note
DRP Recommend Plan
PCPPD-7-Care Plan-2013-NK-AA-TN
Documenting a Care Plan…
PCPPD-7-Care Plan-2013-NK-AA-TN
HOAP Format
History Observation Assessment Plan
Expanded – SOAP Format
Subjective Objective Assessment Plan Goals Monitoring Education
SOAP Format
Subjective Objective Assessment Plan
Hurley SC. A Method of Documenting Pharmaceutical Care Utilizing Pharmaceutical Diagnosis. AJPE.
1998;68:119-127.
Documenting a Care Plan…
PCPPD-7-Care Plan-2013-NK-AA-TN
FARM Format
Findings Assessment Resolution Monitoring
DAR Format
Data Action Response
SOAPIER Format
Subjective Objective Assessment Plan Implement Evaluation Revision
Hurley SC. A Method of Documenting Pharmaceutical Care Utilizing Pharmaceutical Diagnosis. AJPE.
1998;68:119-127.
Documenting a Care Plan The SOAP Note
• SOAP: Subjective, Objective, Assessment, Plan
• A method of documentation employed by health care
providers to write out notes in a patient's chart, along with
other common formats, such as the admission note
• All medical, surgical, nursing specialties use the SOAP notes
• Useful tool to pass along information when transitioning
patient care from one person to another:
– Shift changes
– From one healthcare field to another
– Guidance for future encounters
• Also, useful tool for use by the practitioner in the routine care
for the patient
PCPPD-7-Care Plan-2013-NK-AA-TN
Subjective
Information the pt tells you about him/herself:
1. Chief Complaint (CC) …46yo M presents to pharmacy for hypertension
2. History of Present Illness (HPI) …pt reports elevated readings for 2
weeks
3. Past Medical History (PMH) …has had DM II for 6 years, HTN for 10
years
4. Drug History (DH) …currently taking metformin 1000mg BID, HCTZ
25mg daily
5. Family History (FH) …DMII in both siblings, father died of MI at 52yo
6. Social History (SH) …denies alcohol, illicit drugs. Smokes 1 ppd.
Adheres to diet ~50% of the time
PCPPD-7-Care Plan-2013-NK-AA-TN
Documenting a Care Plan The SOAP Note…
Objective
Observable/factual information obtained from or
verified by a healthcare provider
• Vital signs (BP, HR, RR, temp, wt, ht)
• Physical Exam
• Labs (blood tests, urine tests, microbiology, etc)
• Diagnostic tests (x-rays, CT/MRI, EKG, EEG)
• Medications (from profile or chart)
PCPPD-7-Care Plan-2013-NK-AA-TN
Documenting a Care Plan The SOAP Note…
Assessment
Your clinical judgment of the patient’s DRPs
• Problem list (numbered)
• Each item should include
– problem, solution, evidence/reason for your solution
• Prioritize problems
– start with most urgent (usually relates to CC)
– end with least urgent
…HTN is currently uncontrolled on HCTZ alone. Pt should be on
combo therapy with an ACE-Inhibitor per JNC-7 guidelines.
PCPPD-7-Care Plan-2013-NK-AA-TN
Documenting a Care Plan The SOAP Note…
Plan
• Specific solution for each problem outlined in the
assessment
• Numbered list to match the Assessment
• Recommendations for drug dose, frequency,
duration
• Monitoring
• Follow-up
PCPPD-7-Care Plan-2013-NK-AA-TN
Documenting a Care Plan The SOAP Note…
Documenting a Care Plan Systematic Approaches to Care Planning
PCPPD-7-Care Plan-2013-NK-AA-TN
PWDT
• Pharmacist’s
• Workup of
• Drug
• Therapy
PMDRP
• Pharmacist’s
• Monitoring of
• Drug
• Related
• Problems
PPCP
• Pharmacist’s
• Care
• Plan
Hurley SC. A Method of Documenting Pharmaceutical Care Utilizing Pharmaceutical Diagnosis. AJPE.
1998;68:119-127.
Documenting a Care Plan Systematic Approaches to Care Planning…
PCPPD-7-Care Plan-2013-NK-AA-TN
Pharmacist’s Workup of Drug Therapy (PWDT)
• Establishing patient-specific data-base
• Identifying patient-specific drug-related problems
• Describing desired therapeutic outcomes
• Listing all therapeutic alternatives that might produce the
desired outcomes
• Selecting the drug recommendation that most likely will result
in the desired outcomes
• Establish a plan for therapeutic drug monitoring: documents
the desired effect occur and undesired effects are minimized
Strand, L.M., Cipolle, R.J. and Morley, P.C., “Documenting the clinical pharmacists activities: Back to basics,”
Drug. Intell. Clin. Pharm. 1988;22:63-67.
PWDT Step 4
Feasible
pharmacotherapeutic
alternatives for each DRP
Step 3
Desired
pharmacotherapeutic
Outcomes for each DRP
Step 5
Choose the best pharmaco
therapeutic
Solution and individualize
the therapeutic regimen
Step 6
Therapeutic drug
monitoring plan
Step 7
Implement the
individualized
regimen
And monitoring plan
Step 2
Patient specific DRPs Step1
Patient database
Step 9
Discharge summary
And communication
Step 8
Follow up
Pharmacist’s Patient Data Base Model
The daily care plan
Experience from Hamad General Hospital
Dr. Talal Nassar; B.Pharm. PharmD
MICU clinical pharmacist
HGH April, 24th. 2013
Objectives
• Explain the importance of documentation for a clinical
pharmacist
• Describe the elements of daily care plan
• Explain the need for daily clinical plan updating
• Explain how the daily clinical care plan updating will
help optimizing the therapeutic goals
• Explain the clinical and economic outcomes of daily
clinical plan updating
Documentation
• Pharmaceutical care is the direct,
responsible provision of medication-
related care for the purpose of achieving
definite outcomes that improve a patient’s
quality of life ¹
Documentation
• Documentation is a key for successful communication
between partners (clinical pharmacists)
• Ensure that the patient’s care is evident regarding
therapy, safety and quality
• Documentation translates the pharmacist’s follow up of
a patient’s case status
Documentation
• Reconciliation is a part of documentation
• Documentation is a rich source of
information for research or education
• Documentation and billing issues
Elements of daily care plan
• Patient’s care process starts by knowing your patient
and his/her case
• This process needs first to understand how to present
a case
• Then you need to understand how the MD think about
the case and what are his/her concerns
Elements of daily care plan
• What does a case presentation contain
Chief complain
Patient’s information
Demographic background: age, sex, race, weight, height, allergy
Family and social history
Disease information
HPI (time is very important)
PMH (time is very important)
PSH (time is very important)
Past medication history (reconciliation)
Elements of daily care plan
Review of systems
Physical examination
Vital signs: T, BP, HR, RR (SO2)
GEN, HEENT, NECK, CV, LUNGS, ABD, EXT, NEURO, PSYCH, SKIN, GU, Pelvic,
RECTAL, LYMPH, Mmsk
Lab results (chem7, CBC, ….)
Imaging studies (X-ray, CT, Echo, U/S…)
Current medications at ward
Assessment and plan
Elements of daily care plan
• After collecting these information and understand it, it is time to integrate it
Determine whether the treatment is appropriate, safe and
convenient for the patient in terms of your goals
Identify any drug-related problems that may interfere your
goals
Identify any potential drug-related problems that require
prevention
Keep in mind what and when do you expect results or side
effects from your treatment or adjusting therapy
Specify your follow up monitoring plan regarding therapy
The need for daily clinical updating
• The updating includes (not exclusive to)
Vital signs
Labs, cultures, …
Any new X-ray, CT, MRI, …
Any update in consultations (from other specialties and how this
will affect your therapy target)
Update patient’s medications (D/C, hold, delay in supply…) since
this may affect the time of your target or therapy goals
Update of IV fluids, In-Out, O2 requirements…
Update your monitoring parameters
The need for daily clinical
updating • Always ask on daily basis
• WHY
• DOES THE PATIENT NEED IT
• IS IT THE BEST TREATMENT
• WHAT I SHOULD DO NOW
» SHOULD I ADJUST DOSE
» SHOULD I DISCONTIUE, HOLD,
CHANGE or CONTINUE
The need for daily clinical
updating
• Monitor patient’ response including safety and effectiveness
• Follow up the improvement, if not why or worsening
• May change our care plan goals, therapeutic target…
• May ask for a new test, EKG…
• To prevent any worsening in a drug therapy if happens
• Full information for a research or education
• To take an appropriate action in appropriate time for any new
addressing problems
The daily clinical updating
• By updating clinical care daily
Optimize therapy according to patient’s status
Prevent or reduce problems
Reduce mortality and morbidity
Help other team members
Document interventions
Give an excellent picture about us as clinical pharmacists
which will reflects positively on our future
Economic outcomes of daily clinical
plan updating
• Remove unnecessary therapy
• May reduce cost by changing therapy ( IV to oral, IV
insulin to S/C …)
• Help reducing work load such as repeat
unnecessary labs (like HgA1C, TSH, Lipids…)
• Reduce morbidity and complications
• May reduce hospital stay
• May reduce re-admission
References
• American Society of Health-System Pharmacists. ASHP guidelines on documenting
pharmaceutical care in patient medical records. Am J Health-Syst Pharm. 2003; 60:705–7
• Pharmacotherapy- A Pathophysiologic Approach, 7th ed, 2008
• Appendix 4, Pharmaceutical care planning: The systemic approach.
http://www.scotland.gov.uk/Publications/2010/01/07144120/11
• Principles of Practice for Pharmaceutical Care. American Pharmacist Association.
http://www.pharmacist.com/principles-practice-pharmaceutical-care
Case discussion
• 52 years old Indian male brought to ER by EMS due to decrease of consciousness, weakness in the right part of the body. He has been admitted before 2 months due to AKI
PMH: DM II for the last 10 years, HTN for the last 7 years, A Fib for the last 3 years, CKD stage 2
PSH: no
FH: F and M (DM II), HTN, F had CAD at age of 52
SH: smoker for 20 years, no alcohol, no illicit
Medications history: warfarin 3 mg daily, insulin glargin 20 units pm, insulin lispro 5 units TID, amlodipine 10 mg
ROS: pt unconscious, no fever, no head trauma, no vomiting, move eye for pain stimuli, Palpitations, no wheezing, no swelling, no bedsore or rashes,
PE:
Vitals: BP 195/107, T 37.2, HR 127, RR 22, O2Sat 95% RA
HEENT: PERRLA
Chest: Lungs clear to auscultation bilaterally, pt intubated
CV: A fib, S1 +S2
Neuro: GCS 6, power LUE 0/5, LLE: 0/5, (hemiplegia)
Labs: normal but SrCr: 1.8 mg/dl, BG: 237 mg/dl, WBC: 13000,
CT shows hypodense area suggest hematoma, 2.6*1.7*2.1 seen in the posterior limb of the left internal capsule with minimal edema
Assessment: a case of DMII, HTN, A fib on warfarin, CKD 2, admitted due to ICH
Current medications: phenytoin 100mg IV tid, amlodipine 10 mg, esomeprazole 40mg, glargin 20 units, ceftriaxone 2 g BID IV
The Patient-Centered
Pharmaceutical Care Plan (PPCP)
Nadir Kheir, PhD
PCPPD-7-Care Plan-2013-NK-AA-TN
Implementing Pharmaceutical Care: Using a structured thought process for making
clinical decisions
Patient
Consultation
Assessment Care Plan &
Education
Monitoring &
Follow-up
Gauges patients’
concerns, beliefs,
desires of therapy
Understand
medication taking
behavior
Obtain med
history
Obtain current
med list
Document
Assesses entire
drug history,
looking for
actual or
potential DRPs.
Document
Develops care plans
to eliminate DRPs
and maximize
therapy outcomes.
Provide education
on use of medicine
Document
Monitors to assess
the progress
towards
therapeutic goals
Ensures that
new DRPs are
avoided, &
outcomes
evaluated.
Document
PCPPD-7-Care Plan-2013-NK-AA-TN
Care Planning in Pharmaceutical Care
1. The PCP is a patient-centered document that follows
patient consultation and assessment in the process
of Pharmaceutical Care (PC)
2. The content of a PCP are determined by the
information gathered and DRPs identified during the
assessment and consultation step
3. The PCP is usually formulated by the PC practitioner
separately and discussed with the patient afterwards
PCPPD-7-Care Plan-2013-NK-AA-TN
Care Planning in Pharmaceutical Care…
4. The PCP must be agreeable and comprehensible by
the patient
5. Monitoring/evaluation is conducted by the PC
practitioner with reference to the desired outcomes
articulated in the PCP (including clinical, laboratory,
humanistic and other outcomes)
PCPPD-7-Care Plan-2013-NK-AA-TN
Care Planning in Pharmaceutical Care…
PCPPD-7-Care Plan-2013-NK-AA-TN
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: The clinician’s guide. 2nd Edition.
New York: McGraw Hill; 2004.
Summary: Foundations of a PCP
• The care plan organizes all the patient’s drug therapy and other interventions and help to optimize treatment
• The care plan includes measurable desired outcomes
• A care plan is developed as a result of analyzing all findings from the assessment process
• The care plan is organized by each medical condition (indication) and its pharmacotherapy (1 care plan per indication for drug therapy)
• The care plan must be negotiated with (and agreed for by) the patient
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: The clinician’s guide. 2nd
Edition. New York: McGraw Hill; 2004.
PCPPD-7-Care Plan-2013-NK-AA-TN
The PCP:
• Includes strategies to improve compliance
• Includes interventions to improve drug therapy outcome, and eliminate (or prevent) drug therapy problems
• Includes advice on how to measure disease markers at home, when to seek medical help, and when to see the PC practitioner next
Accurate and detailed assessment results in relevant and successful care plan
PCPPD-7-Care Plan-2013-NK-AA-TN
Starting the Process
Establish therapeutic relationship:
- Meet and greet: introduce self (title, name)
- Explain the reason for the encounter, or ask for the patient’s reason (what can I do for you today?)
- Be structured, friendly, professional
- Prepare: time, information, background
- Prepared physical environment:
- Semi-private space
- Comfortable, professional, equipped
- No distraction
- Complete focus
PCPPD-7-Care Plan-2013-NK-AA-TN
Patient’s Own Description of Experience
• First step in the Consultation phase (after developing the therapeutic relationship)
• Information sought includes:
- what’s the patient attitude towards taking medicines (drugs don’t work, I don’t take meds)
- what does the patient expect/desires from therapy (needs vs. wants)
- any concerns (AEs, how to take meds and why)
- any cultural, religious, ethical issues that could affect the patient’s ability to take medication
Important starting point, allows you to plan
changes to influence patient’s attitudes PCPPD-7-Care Plan-2013-NK-AA-TN
History of
drug abuse
Concern of
bladder ca
History of
smoking
Duodenal
ulcer
Poorly controlled
Blood pressure
History of
Depression
Age &
Disability
?
Disease
Illness &
Concerns
Stroke
Shaking hands
From: Kheir N. Taped Consulting Session
PCPPD-7-Care Plan-2013-NK-AA-TN
Patient’s Medication Taking Behavior
Patient medication experience determines medication taking behavior (MTB)
MTB is the decision the patient makes in regards to the use of drug therapy
This has impact on whether:
- The patient takes the medication
- The patient stops taking a medication
- The patient refills a prescription
- The patient becomes fully compliant
PCPPD-7-Care Plan-2013-NK-AA-TN
Current Medication Record
All current health conditions and medications
Record for each drug
- generic & brand names
- indication
- dosage regimen: dose, frequency, duration
- how actually taken
- start day: checking temporal relationship in allergy, determine time to take effect
- response: stable, improved, partially improved, worsened, resolved, failed The process leads to analysis, identifying DRPs,
and Development of a Care Plan
PCPPD-7-Care Plan-2013-NK-AA-TN
PCP:
Activities & Responsibilities
Activity Responsibility
Establish goals of therapy Negotiate with the patient, agree on
desired outcomes, explain roles &
responsibilities
Determine interventions
to resolve or prevent
DRPs, and achieve
desired therapy outcomes
Discuss with patient, provide education
and training, use leaflets, contact other
healthcare providers, negotiate
interventions, advice on alternative
therapy and non-drug therapy
Schedule follow-up Agreed follow-up schedule to monitor
change and address any developing
issues
Adapted from: Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: The clinician’s
guide. 2nd Edition. New York: McGraw Hill; 2004.
PCPPD-7-Care Plan-2013-NK-AA-TN
Care Planning: 1. Determining Desired Goals of Therapy
• Goals of therapy must be set (for each condition) to
allow follow-up of care plan success
• Goals of therapy must be patient-centered
• Goals of therapy must be based on mutual agreement
and negotiation between the PC clinician and the patient
• Goals of therapy are based on clinical measurable or
observable indicators
• Multiple drug therapies for the same indication are
grouped together in the same care plan (i.e. 3 drugs
taken by the patient to treat hypertension)
•
PCPPD-7-Care Plan-2013-NK-AA-TN
Goals of Therapy as SMART Objectives
• Specific
• Measurable
• Achievable
• Realistic
• Time-bound
Each single
goal of
therapy must
be SMART
Subjective
outcomes are
measurable
from the
patient’s
description
PCPPD-7-Care Plan-2013-NK-AA-TN
General Goals of Therapy
• Curing a disease
• Eliminate signs and/or symptoms
• Slow progression of a disease
• Prevent a disease
• Normalize laboratory values
• Assist in the diagnostic process
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: The clinician’s guide. 2nd Edition. New York:
McGraw Hill; 2004.
PCPPD-7-Care Plan-2013-NK-AA-TN
Goals of Therapy (Desired Outcomes)
What you are trying to
accomplish with
pharmacotherapy
How long it
will take
Time Frame
Improvements in clinical signs and
symptoms (observed values)
Changes in laboratory test results as
evidence of improvements (measured
values)
When to expect evidence
of improvement
Time required to achieve
full therapeutic response
Parameter
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: The clinician’s guide. 2nd Edition. New York:
McGraw Hill; 2004.
PCPPD-7-Care Plan-2013-NK-AA-TN
The Skill to Decide Desired Outcomes
Usually, desired outcomes aim at:
• Approaching normal physiology (i.e., normalize blood
pressure)
• Slowing progression of disease (i.e., slow progression
of cancer)
• Alleviating symptoms (i.e., optimize pain control)
• Preventing adverse effects
• Educate the patient about his or her medication
• Improving compliance with drug regimen
• Applying life-style changes (promoting health) to
maximize benefits of drug therapy
PCPPD-7-Care Plan-2013-NK-AA-TN
Structure of Desired Outcomes
• Clinical parameter:
- observable, measurable, and realistic signs, symptoms and/or laboratory values
• A desired value or observable change in the parameter
• A specific timeframe in which the goal is to be met
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: The clinician’s guide. 2nd Edition. New York:
McGraw Hill; 2004.
PCPPD-7-Care Plan-2013-NK-AA-TN
Examples of SMART Goals of Therapy
Medical Condition Goal of Therapy
Strep pneumonia, tuberculosis,
constipation
Cure of a disease
Depression, asthma Reduction or elimination of
signs and symptoms
Diabetes, hypertension,
dyslipidaemia
Slow or halt the progression of
disease
MI, osteoarthritis Prevent a disease
Anaemia, hypokalaemia Normalize lab values
See Table 8-4 (Goals of therapy for common medical conditions),
Cipolle et al, 2004; Establishing goals of therapy, pg 209-10)
PCPPD-7-Care Plan-2013-NK-AA-TN
Care Planning: 2. Making Interventions
• The purpose of interventions in the care
plan is to achieve goals of therapy, and
address DRPs
• All interventions are made with
consideration to:
- Measured and/or observed parameters
- Best practice & treatment guidelines
- Desired therapy outcomes
PCPPD-7-Care Plan-2013-NK-AA-TN
Making Interventions
• Each intervention (see next slide) is developed
and discussed with the patient, and other
significant others (who?)
• Each intervention is documented
• Each intervention should be expected to
help achieve desired outcomes (goals)
PCPPD-7-Care Plan-2013-NK-AA-TN
Care Plan: The SIX Interventions
• Initiate new drug therapy
• Increase dosages
• Decrease dosage
• Discontinue drug therapy
• Referrals
• Provide instructions for optimal use of
medications
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: The clinician’s guide. 2nd Edition. New York:
McGraw Hill; 2004.
PCPPD-7-Care Plan-2013-NK-AA-TN
Discussing/Negotiating the Plan
• Discuss the action plan in a dedicated scheduled meeting
• Discuss each element in the plan
• Explain how each point would help the patient achieve specific desired outcome
• Be ready to alter the plan based on the patient’s preference while still achieving the desired outcomes
• Schedule a follow-up meeting to monitor (ensure timeframe is suitable to measure change)
PCPPD-7-Care Plan-2013-NK-AA-TN
Scheduling Follow-up and Evaluation
• Pre-set desired outcomes: clinical, lab, subjective
• Be clear what is required of the patient”
- Our next meeting should be in xx wks
- What date suits you the best?
- Can we contact you? Where?
- Do you have any issues you would like to discuss
about your care plan?
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: The clinician’s guide. 2nd Edition. New York:
McGraw Hill; 2004.
PCPPD-7-Care Plan-2013-NK-AA-TN
The “Structure” of a Care Plan? Patient-Oriented Type of Care Plan
PCPPD-7-Care Plan-2013-NK-AA-TN
PCPPD-7-Care Plan-2013-
NK-AA-TN
A Demonstration:
Filled Form
PCPPD-7-Care Plan-2013-
NK-AA-TN
PCPPD-7-Care Plan-2013-
NK-AA-TN
PCPPD-7-Care Plan-2013-
NK-AA-TN
PCPPD-7-Care Plan-2013-
NK-AA-TN
PCPPD-7-Care Plan-2013-NK-AA-TN
THANK YOU
How many times?